title: Plasma renin and aldosterone in thyroid diseases.
abstract: The effect of thyroid hormones on the renin-angiotensin-aldosterone system has not been fully resolved. Highly specific immunoassays for measurement of renin, aldosterone, free T4 (fT4), free T3 (fT3) and ultrasensitive TSH enables a direct and more accurate measurement of these hormones. We investigated the relationship between plasma renin, aldosterone and thyroid hormones in the basal state and after intravenous frusemide. This is a cross-sectional study involving 37 patients with thyrotoxicosis, 42 rendered euthyroid with normal fT4, fT3 and TSH levels, 17 with euthyroid levels of fT4 and fT3 but suppressed TSH, and 11 with hypothyroidism. Basal plasma renin was significantly higher in thyrotoxicosis (63.4 +/- 9.8 microU/ml, mean +/- SEM) compared to euthyroid (32.7 +/- 4.4 microU/ml) and hypothyroid (26.7 +/- 9.8 microU/ml). Basal plasma renin for euthyroid with suppressed TSH (41.0 +/- 7.4 microU/ml) was significantly higher than hypothyroid (p = 0.02). Basal plasma aldosterones were not significantly different except for suppressed TSH (157.7 +/- 13 pg/ml), which was higher than normal (109.9 +/- 10.4 pg/ml; p = 0.04). Following frusemide, plasma renin and aldosterone were significantly increased in all groups. Plasma renin was highly correlated to fT3 (r = 0.405, p < 0.001), total T3 (r = 0.359, p < 0.001), fT4 (r = 0.331, p < 0.001) and TSH (r = 0.300, p < 0.001) in the basal state, but less to total T4 (r = 0.248, p < 0.01). Plasma renin correlated poorly to serum aldosterone (r = 0.212, p < 0.03). This study clearly showed that regulation of renin was mainly influenced by fT3, and that aldosterone response to frusemide was blunted in thyrotoxicosis despite normal electrolytes.
authors.affiliation: Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia.
authors.forename: B J
authors.initials: BJ
authors.lastname: Asmah
authors.forename: W M
authors.initials: WM
authors.lastname: Wan Nazaimoon
authors.forename: K
authors.initials: K
authors.lastname: Norazmi
authors.forename: T T
authors.initials: TT
authors.lastname: Tan
authors.forename: B A
authors.initials: BA
authors.lastname: Khalid
mesh_terms: D000450:Aldosterone / Q000097:blood*; D003430:Cross-Sectional Studies; D004232:Diuretics / Q000008:administration & dosage; D005665:Furosemide / Q000008:administration & dosage; D006801:Humans; D007037:Hypothyroidism / Q000097:blood; D011188:Potassium / Q000097:blood / Q000652:urine; D012083:Renin / Q000097:blood* / Q000187:drug effects; D012964:Sodium / Q000097:blood / Q000652:urine; D013959:Thyroid Diseases / Q000097:blood*; D013971:Thyrotoxicosis / Q000097:blood; D013972:Thyrotropin / Q000097:blood / Q000187:drug effects; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D004232:Diuretics; D014284:Triiodothyronine; D000450:Aldosterone; D005665:Furosemide; D013972:Thyrotropin; D012964:Sodium; D012083:Renin; D013974:Thyroxine; D011188:Potassium